7Baggers
 KPRX - Kiora Pharmaceuticals Inc Latest SEC Filings  Finviz Sat, 04 Jul 2026 14:28:33 GMT
 kiora pharmaceuticals closes $24m private placement  Investing.com Sat, 04 Jul 2026 07:45:04 GMT
 Form 4 Kiora Pharmaceuticals Inc For: 2 July By Investing.com  Investing.com India Thu, 02 Jul 2026 21:02:34 GMT
 Kiora (NASDAQ: KPRX) CFO uses 911 shares to cover tax obligations  Stock Titan Thu, 02 Jul 2026 20:47:45 GMT
 [Form 4] KIORA PHARMACEUTICALS INC Insider Trading Activity  Stock Titan Thu, 02 Jul 2026 20:47:16 GMT
 Kiora Pharmaceuticals to present at Piper Sandl...  Pluang Thu, 02 Jul 2026 11:20:41 GMT
 Kiora set for Piper Sandler fireside chat on July 9  Stock Titan Thu, 02 Jul 2026 11:00:00 GMT
 Kiora Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:KPRX)  TradingView Fri, 26 Jun 2026 09:08:01 GMT
 KPRX Forecast — Price Target — Prediction for 2027  TradingView Fri, 26 Jun 2026 07:33:14 GMT
 7ey forecast — price target — prediction for 2027  TradingView Fri, 26 Jun 2026 05:58:47 GMT
 why did kprx stock surge 17% pre-market today?  Stocktwits Wed, 24 Jun 2026 20:48:03 GMT
 why did kprx stock surge 17% pre-market today?  Stocktwits Sun, 21 Jun 2026 07:02:15 GMT
 kprx sec filings - kiora pharmaceuticals inc 10-k, 10-q, 8-k forms  Stock Titan Fri, 19 Jun 2026 11:15:34 GMT
 kiora showcases promising preclinical epilepsy data for kio-300  TipRanks Thu, 18 Jun 2026 11:46:16 GMT
 kiora presents preclinical epilepsy data for retinal drug by investing.com  Investing.com UK Thu, 18 Jun 2026 11:14:00 GMT
 kiora pharmaceuticals inc (kprx) institutional confidence  TradingKey Thu, 18 Jun 2026 07:14:42 GMT
 Kiora's KIO-300 cut epileptiform activity in epilepsy model  Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
 kiora pharmaceuticals (kprx) director awarded 25,000 stock options  Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
 kiora pharmaceuticals shareholders approve expanded equity incentive plan  The Globe and Mail Fri, 12 Jun 2026 07:00:00 GMT
 why did kprx stock surge 17% pre-market today?  Stocktwits Fri, 05 Jun 2026 22:14:55 GMT
 kprx - kiora pharmaceuticals inc. stock news, filings & ratings  Quantisnow Fri, 29 May 2026 04:45:51 GMT
 KPRX - Kiora Pharmaceuticals Inc Stock Price and Quote  Finviz Tue, 26 May 2026 16:13:12 GMT
 [effect] kiora pharmaceuticals inc sec filing  Stock Titan Tue, 26 May 2026 10:29:54 GMT
 [effect] kiora pharmaceuticals inc sec filing  Stock Titan Mon, 25 May 2026 07:00:00 GMT
 kiora pharmaceuticals (nasdaq: kprx) registers 11.8m resale shares  Stock Titan Mon, 18 May 2026 07:00:00 GMT
 alyeska files 13g for kiora (nasdaq: kprx) reporting 9.99% stake  Stock Titan Fri, 15 May 2026 07:00:00 GMT
 nantahala reports 9.99% stake in kiora pharmaceuticals (kprx)  Stock Titan Fri, 15 May 2026 07:00:00 GMT
 tradingkey  TradingKey Tue, 12 May 2026 10:25:21 GMT
 edgar filing documents for 0001372514-23-000110  SEC.gov Sat, 09 May 2026 00:44:10 GMT
 kprx sec filings - kiora pharmaceuticals inc 10-k, 10-q, 8-k forms  Stock Titan Fri, 08 May 2026 16:33:48 GMT
 form 8k kiora pharmaceuticals inc for: 8 may  Investing.com South Africa Fri, 08 May 2026 07:00:00 GMT
 kiora says cash lasts into late 2028 as retinal studies advance  Stock Titan Fri, 08 May 2026 07:00:00 GMT
 [ars] kiora pharmaceuticals inc sec filing  Stock Titan Fri, 01 May 2026 07:00:00 GMT
 kprx sec filings - kiora pharmaceuticals inc 10-k, 10-q, 8-k forms  Stock Titan Fri, 01 May 2026 01:28:16 GMT
 kphmw sec filings - kiora pharma 10-k, 10-q, 8-k forms  Stock Titan Tue, 28 Apr 2026 15:22:09 GMT
 lytham spotlight series | kiora pharmaceuticals (nasdaq: kprx) (mdojqdglak)  fathomjournal.org Sat, 25 Apr 2026 05:27:20 GMT
 kiora pharmaceuticals (kprx) industry outlook | q4 2025: earnings underperform - global trading community  Cổng thông tin điện tử tỉnh Tây Ninh Thu, 23 Apr 2026 02:17:58 GMT
 kiora publishes phase 1 results for retinal disease drug in journal  Investing.com Tue, 14 Apr 2026 07:00:00 GMT
 perceptive fund (rlay) reports 9.99% ownership — 438,471 shares  Stock Titan Mon, 13 Apr 2026 07:00:00 GMT
 kprx technical analysis & etf price forecast  Intellectia AI Thu, 09 Apr 2026 13:43:02 GMT
 kprx hits 60-day high on barely a whisper of volume  Bitget Tue, 07 Apr 2026 12:52:02 GMT
 Kiora Pharmaceuticals closes $24M private placement  Investing.com Tue, 07 Apr 2026 07:00:00 GMT
 Kiora Pharmaceuticals’ Stock Analysis amidst Financial Challenges  StocksToTrade Tue, 07 Apr 2026 07:00:00 GMT
 KPRX Faces Tumultuous Trading: Strategic Moves Amid Market Fluctuations  timothysykes.com Tue, 07 Apr 2026 07:00:00 GMT
 two biotech investors back kiora with $5m now, $19m more later  Stock Titan Tue, 07 Apr 2026 07:00:00 GMT
 why did kprx stock surge 17% pre-market today?  Stocktwits Tue, 07 Apr 2026 07:00:00 GMT
 kprx hits 60-day high on barely a whisper of volume  Bitget Mon, 06 Apr 2026 21:45:52 GMT
 kiora pharmaceuticals chief development officer to depart by investing.com  Investing.com India Fri, 03 Apr 2026 07:00:00 GMT
 Kiora Pharmaceuticals Announces Management Team Changes  TMX Newsfile Thu, 02 Apr 2026 07:00:00 GMT
 kiora pharmaceuticals chief development officer to depart  Investing.com Thu, 02 Apr 2026 07:00:00 GMT
 kiora says retinal disease trials keep enrolling after exec exit  Stock Titan Thu, 02 Apr 2026 07:00:00 GMT
 kiora pharmaceuticals (kprx) cfo uses 929 shares to cover taxes  Stock Titan Thu, 02 Apr 2026 07:00:00 GMT
 kiora (kprx) ceo withholds 1,906 shares to cover stock taxes  Stock Titan Thu, 02 Apr 2026 07:00:00 GMT
 kprx stock news today | earnings, events & price alerts  Intellectia AI Wed, 01 Apr 2026 09:34:06 GMT
 kiora pharmaceuticals 10-k: $0m revenue, $(10.84)m net loss  TradingView Wed, 25 Mar 2026 11:05:01 GMT
 retinal disease pipeline at kiora pharmaceuticals (nasdaq: kprx)  Stock Titan Wed, 25 Mar 2026 11:01:51 GMT
 kiora pharmaceuticals reports $10.8m loss for 2025  Investing.com Wed, 25 Mar 2026 07:00:00 GMT
 kiora pharmaceuticals posts 2025 net loss as expenses rise  TradingView Wed, 25 Mar 2026 07:00:00 GMT

Kiora Pharmaceuticals, Inc.
(NASDAQ:KPRX) 

KPRX stock logo

Kiora Pharmaceuticals, Inc., an ophthalmic specialty pharmaceutical company, develops therapies for the treatment of eye diseases in the United States. Its pipeline includes KIO-101, a small molecule DHODH inhibitor that treats immunologic eye diseases; KIO-201, an eye drop that enhances ocular woun...

Founded: 1998
CEO: Brian M Strem  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends